MEDNATION AG (EIF.DE) Fundamental Analysis & Valuation

FRA:EIF • DE0005653604

3.36 EUR
+0.02 (+0.6%)
Last: Mar 3, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This EIF.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

3

EIF gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 33 industry peers in the Health Care Providers & Services industry. EIF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. EIF is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. EIF.DE Profitability Analysis

1.1 Basic Checks

  • EIF had positive earnings in the past year.
  • EIF had a positive operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: EIF reported negative net income in multiple years.
  • EIF had a positive operating cash flow in each of the past 5 years.
EIF.DE Yearly Net Income VS EBIT VS OCF VS FCFEIF.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2M -2M 4M -4M

1.2 Ratios

  • EIF has a worse Return On Assets (1.58%) than 63.64% of its industry peers.
  • The Return On Equity of EIF (4.66%) is worse than 60.61% of its industry peers.
  • The Return On Invested Capital of EIF (1.64%) is worse than 84.85% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for EIF is below the industry average of 6.06%.
Industry RankSector Rank
ROA 1.58%
ROE 4.66%
ROIC 1.64%
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
EIF.DE Yearly ROA, ROE, ROICEIF.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40

1.3 Margins

  • Looking at the Profit Margin, with a value of 1.13%, EIF is in line with its industry, outperforming 45.45% of the companies in the same industry.
  • Looking at the Operating Margin, with a value of 2.34%, EIF is doing worse than 72.73% of the companies in the same industry.
  • EIF's Operating Margin has declined in the last couple of years.
  • EIF's Gross Margin of 91.35% is amongst the best of the industry. EIF outperforms 90.91% of its industry peers.
  • EIF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.34%
PM (TTM) 1.13%
GM 91.35%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
EIF.DE Yearly Profit, Operating, Gross MarginsEIF.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. EIF.DE Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EIF is destroying value.
  • Compared to 1 year ago, EIF has less shares outstanding
  • The number of shares outstanding for EIF has been reduced compared to 5 years ago.
  • EIF has a better debt/assets ratio than last year.
EIF.DE Yearly Shares OutstandingEIF.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
EIF.DE Yearly Total Debt VS Total AssetsEIF.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • EIF has an Altman-Z score of 1.97. This is not the best score and indicates that EIF is in the grey zone with still only limited risk for bankruptcy at the moment.
  • EIF has a Altman-Z score (1.97) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.98 indicates that EIF is somewhat dependend on debt financing.
  • EIF has a Debt to Equity ratio (0.98) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Altman-Z 1.97
ROIC/WACC0.37
WACC4.45%
EIF.DE Yearly LT Debt VS Equity VS FCFEIF.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M 50M

2.3 Liquidity

  • A Current Ratio of 1.73 indicates that EIF should not have too much problems paying its short term obligations.
  • The Current ratio of EIF (1.73) is better than 78.79% of its industry peers.
  • EIF has a Quick Ratio of 1.50. This is a normal value and indicates that EIF is financially healthy and should not expect problems in meeting its short term obligations.
  • EIF's Quick ratio of 1.50 is amongst the best of the industry. EIF outperforms 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 1.5
EIF.DE Yearly Current Assets VS Current LiabilitesEIF.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. EIF.DE Growth Analysis

3.1 Past

  • EIF shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -56.51%.
  • The Revenue has been growing slightly by 4.11% in the past year.
  • The Revenue has been growing slightly by 0.13% on average over the past years.
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EIF.DE Yearly Revenue VS EstimatesEIF.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

Find the best growth stocksShow best growing peers

1

4. EIF.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 17.68, the valuation of EIF can be described as rather expensive.
  • The rest of the industry has a similar Price/Earnings ratio as EIF.
  • EIF's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 25.71.
Industry RankSector Rank
PE 17.68
Fwd PE N/A
EIF.DE Price Earnings VS Forward Price EarningsEIF.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EIF indicates a slightly more expensive valuation: EIF is more expensive than 63.64% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.59
EIF.DE Per share dataEIF.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. EIF.DE Dividend Analysis

5.1 Amount

  • EIF does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

EIF.DE Fundamentals: All Metrics, Ratios and Statistics

MEDNATION AG

FRA:EIF (3/3/2026, 7:00:00 PM)

3.36

+0.02 (+0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-30
Earnings (Next)N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners25.13%
Ins Owner ChangeN/A
Market Cap10.48M
Revenue(TTM)50.89M
Net Income(TTM)575.90K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 17.68
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF 27.37
P/B 0.85
P/tB 0.85
EV/EBITDA 10.59
EPS(TTM)0.19
EY5.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)0.12
OCFY3.65%
SpS16.31
BVpS3.96
TBVpS3.95
PEG (NY)N/A
PEG (5Y)N/A
Graham Number4.12
Profitability
Industry RankSector Rank
ROA 1.58%
ROE 4.66%
ROCE 3.86%
ROIC 1.64%
ROICexc 1.8%
ROICexgc 1.8%
OM 2.34%
PM (TTM) 1.13%
GM 91.35%
FCFM N/A
ROA(3y)-0.31%
ROA(5y)-1.7%
ROE(3y)-5.18%
ROE(5y)-13.87%
ROIC(3y)1.75%
ROIC(5y)N/A
ROICexc(3y)1.97%
ROICexc(5y)N/A
ROICexgc(3y)1.97%
ROICexgc(5y)N/A
ROCE(3y)4.15%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y6.43%
ROICexc growth 3YN/A
ROICexc growth 5Y6.41%
OM growth 3YN/A
OM growth 5Y-8.88%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.52%
GM growth 5Y-0.44%
F-Score5
Asset Turnover1.39
Health
Industry RankSector Rank
Debt/Equity 0.98
Debt/FCF N/A
Debt/EBITDA 6.43
Cap/Depr 60.09%
Cap/Sales 0.81%
Interest Coverage 3.91
Cash Conversion 20.4%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 1.5
Altman-Z 1.97
F-Score5
WACC4.45%
ROIC/WACC0.37
Cap/Depr(3y)35.94%
Cap/Depr(5y)25.78%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-56.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%145.45%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)4.11%
Revenue growth 3Y10.85%
Revenue growth 5Y0.13%
Sales Q2Q%4.89%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.69%
EBIT growth 3YN/A
EBIT growth 5Y-8.76%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-112.02%
FCF growth 3Y-18.54%
FCF growth 5Y-3.22%
OCF growth 1Y-40.8%
OCF growth 3Y-13.99%
OCF growth 5Y-5.06%

MEDNATION AG / EIF.DE FAQ

Can you provide the ChartMill fundamental rating for MEDNATION AG?

ChartMill assigns a fundamental rating of 3 / 10 to EIF.DE.


What is the valuation status for EIF stock?

ChartMill assigns a valuation rating of 1 / 10 to MEDNATION AG (EIF.DE). This can be considered as Overvalued.


Can you provide the profitability details for MEDNATION AG?

MEDNATION AG (EIF.DE) has a profitability rating of 3 / 10.


What are the PE and PB ratios of MEDNATION AG (EIF.DE) stock?

The Price/Earnings (PE) ratio for MEDNATION AG (EIF.DE) is 17.68 and the Price/Book (PB) ratio is 0.85.


How financially healthy is MEDNATION AG?

The financial health rating of MEDNATION AG (EIF.DE) is 5 / 10.